Walleye Capital’s Procept Biorobotics PRCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PRCT
Walleye Capital's PRCT Position: Q3 2026 in Review
Walleye Capital increased its Procept Biorobotics (PRCT) stake by 872% in Q3 2026, buying an estimated $92.5K and bringing the position to 5,173 shares worth $94.3K. The position accounts for ﹤0.01% of the portfolio, ranked #5218.
Walleye Capital first reported a position in PRCT in Q4 2023 and has held it in 8 quarters since. The position peaked at $2.77M in Q2 2024. 232 funds tracked by Wall St. Rank hold PRCT as of Q3 2026.
- Walleye Capital held 5,173 shares of Procept Biorobotics worth $94.3K as of Q3 2026.
- Walleye Capital bought 4,641 Procept Biorobotics shares in Q3 2026, an estimated $92.5K.
- Procept Biorobotics made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #5218 holding.
- Walleye Capital first reported a position in Procept Biorobotics in Q4 2023 and has held it in 8 quarters since.
- Walleye Capital's Procept Biorobotics position peaked at $2.77M in Q2 2024.
- 232 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.